Last month, Google quietly killed off Google Sky Maps. But there’s still another way to virtually explore most of the solar system a la Google Maps: it’s called Google Maps in Space. Google Maps in ...

AI features and a brand new way to view Google Maps are currently rolling out in the app for its biggest upgrade in a decade. Credit: Google Maps Google Maps just got a major upgrade. A really major ...

Monash University researchers, alongside key partner Halozyme Therapeutics, report findings in support of shifting the way anti-cancer immunotherapy is administered from intravenous administration to ...

Subcutaneous (SC) formulations of monoclonal antibodies are rapidly transforming the delivery of cancer immunotherapy. Designed to replace or complement intravenous (IV) administration, SC delivery ...

Google Maps leads the navigation app market, but if you've faced traffic jams while it promised to save time, or lost signal when you needed directions, you know it's not for everyone. Maybe you need ...

Navigation apps have become an essential part of modern life. Whether you are commuting to work, running errands or exploring a new city, relying on accurate directions and real-time traffic updates ...

The FDA has approved a subcutaneous formulation of lecanemab (Leqembi Iqlik, Eisai/Biogen) for maintenance dosing in patients with Alzheimer’s disease (AD) with mild cognitive impairment (MCI) or mild ...

TORONTO -- An investigational subcutaneous autoinjector showed comparable efficacy and safety to the IV formulation of lecanemab (Leqembi) for maintenance treatment in early Alzheimer's disease, ...

Google Maps has been around for nearly two decades and is the most popular navigation app. Waze is more community-centric while Apple Maps has a loyal user base of iPhone owners. Each navigation app ...

Panelists discuss how switching from intravenous (IV) to subcutaneous (SubQ) therapies requires proactive management of reimbursement, authorizations, and clinical workflows—emphasizing early payer ...

The phase 3 IRAKLIA trial found that subcutaneous isatuximab delivered via an on-body system was as effective and safe as intravenous (IV) administration in relapsed/refractory multiple myeloma, ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...